Pharmaceutical preparations company · NV · FY ends Dec · -13381.25% margin · -$2M FCF
The business is unprofitable at the operating level (-13381.25% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Negative free cash flow of -$2M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (FY)
$32K
Net Income (TTM)
-$13M
▲ +52.1% YoY
Op. Margin
-13381.25%
ROIC
-25.36%
▲ +46.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$2M
▲ +33.8% YoY
Op. Cash Flow (TTM)
-$2M
▲ +33.8% YoY
Net Debt
-$20K
Net Cash Position
Cash & Equiv.
$20K
Continue Research